title: Summary of presentations from the 46th annual meeting of the American Society Of Clinical Oncology (2010): focus on developmental therapeutics related to lung cancer.
abstract: A number of novel agents are currently being tested in clinical trials in patients with cancer. Results from early-phase trials, often in unselected groups of patients with a wide variety of cancer types, were reported at the 46th annual meeting of the American Society of Clinical Oncology (ASCO). We report on selected studies from the developmental therapeutics track (abstracts 2500-2613 and 3000-3108) that may be of interest to the thoracic oncology community.
authors.affiliation: Division of Medical Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA.
authors.forename: Daniel
authors.initials: D
authors.lastname: Morgensztern
authors.forename: Nathan A
authors.initials: NA
authors.lastname: Pennell
authors.forename: Janakiraman
authors.initials: J
authors.lastname: Subramanian
authors.forename: Ramaswamy
authors.initials: R
authors.lastname: Govindan
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D015507:Drugs, Investigational / Q000627:therapeutic use*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008495:Medical Oncology; D012955:Societies, Medical; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D015507:Drugs, Investigational